uMed, London (2026)

08/09/2023

We are delighted to announce that uMed are supporting the UK’s largest research programme, Our Future Health UK!

We are working with our vast network of GP partners in the South of the UK to engage volunteers via SMS, inviting them to take part in this revolutionary programme.

Our Future Health will collect and link multiple sources of health and health-relevant information, including genetic data, across a cohort of 5 million people that truly reflects the UK population. This will create a world-leading resource for academic and commercial researchers to undertake discovery research on early indicators of disease, plus the opportunity to re-contact participants on a risk-stratified basis for secondary studies.

Find out more about the partnership here: https://umed.io/news/company/our-future-health-partners-with-umed/

Our Future Health partners with uMed to facilitate recruitment of volunteers across the South of the UK uMed is delighted to announce it is now engaging volunteers for Our Future Health, the UK’s largest health research programme, designed to enable the discovery and testing of more effective appr...

27/04/2022

A great article reviewing the burdens faced by patients in the recruitment process and how the rising use of technology is having both a positive and negative impact on patient enrolment and retention.

Technology can minimise burden on the patient and help them feel valued. However if used incorrectly, these technologies can complicate trial participation and increase the burden. Patients benefit from sponsors that examine and execute strategies to help them feel more valued, better informed, actively engaged in their treatment, and more comfortable with participating.

Read the full article here:

The introduction of increasing amounts of technology into trials has been a double-edged sword. Delve into how, when used properly, these technologies can minimize patient burden and help participants to feel valued; misapplied, they complicate trial participation or increase patient burdens.

19/04/2022

“Patients want to help with research, and it is about providing them the means of doing that in a way that is not burdensome, and that allows them to see how they have contributed”

Listen to uMed Founder Dr. Matt Wilson speak as a guest on the Transformation in Trials about how patients can benefit from population level research, and how automating consent and recruitment processes can broaden the net in terms of the number of patients involved in clinical trials. A broader patient population means that underrepresented groups gain access to clinical trials and this allows a much more detailed characterisation of an overall patient population.

🎙️Listen to the full podcast episode here: https://www.buzzsprout.com/1906263/10458100🎙️

Matt Wilson guests the show and talks to Sam and Ivanna about how automating consent and recruitment processes can broaden the net in terms of the number of patients involved in clinical trials. A broader patient population means that underreprese...

Address

London

Website

https://umed.io/

Alerts

Be the first to know and let us send you an email when uMed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to uMed:

uMed